Literature DB >> 21971199

[Post-stroke depression: recognition and treatment interventions].

S Arseniou1, A Arvaniti, M Samakouri.   

Abstract

Depression is the most common neuropsychiatric complication of a stroke (Post Stroke DepressionPSD) and has been shown to impede the recovery and rehabilitation of these patients. Prevalence rates of PSD vary between 6% and 79%. Direct comparison between studies is limited due to their different methodology. Etiology of PSD is determined by biological and psychosocial factors. Symptoms of PSD appear in three areas: affective, somatic and cognitive. Differential diagnosis includes post-stroke fatigue and pseudo-depressive manifestations of ischemic infarctions (apathy, aprosody, athymhormia, pseudobulbar palsy). Mortality in post-stroke patients is higher than in non-depressed stroke patients and suicide ideation is observed in 6.6-11.3% of stroke patients. Selective serotonin reuptake inhibitors (SSRI) are considered as the first choice treatment of PSD. Other therapeutic approaches include cognitive and functional rehabilitation. PSD is a potentially treatable condition, yet under-diagnosed, and has a negative effect on functional recovery and survival of stroke patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971199

Source DB:  PubMed          Journal:  Psychiatriki        ISSN: 1105-2333


  4 in total

1.  Xingnao Jieyu Decoction Ameliorates Poststroke Depression through the BDNF/ERK/CREB Pathway in Rats.

Authors:  Tao Li; Dou Wang; Bingbing Zhao; Yongmei Yan
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-16       Impact factor: 2.629

2.  Effect of sertraline in the treatment and prevention of poststroke depression: A meta-analysis.

Authors:  Rongfang Feng; Peng Wang; Chenhao Gao; Jianbo Yang; Zixiao Chen; Yaoyao Yang; Jiawei Jiao; Mengmeng Li; Bo Fu; Ling Li; Zhenxiang Zhang; Shiguang Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

3.  Clinical efficacy of Danzhi Xiaoyao Powder in the treatment of post-stroke depression: A protocol for randomized, double-blind clinical study.

Authors:  ChunQin Ding; MingYang Xu; Li Gao; XiaoRong Wang; Wu Xu; MinWang Guo; Jun Yao
Journal:  Medicine (Baltimore)       Date:  2021-10-22       Impact factor: 1.817

4.  Does citalopram effectively treat post-stroke depression?: A protocol for systematic review and meta analysis.

Authors:  Jing Hu; Li Ma; Zeng-Ye Yang
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.